Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Adriana Weinberg

Concepts (839)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
103
2026
3210
10.320
 Why?
Herpes Zoster Vaccine
26
2026
154
9.840
 Why?
Herpes Zoster
33
2025
318
9.080
 Why?
Herpesvirus 3, Human
37
2025
342
7.180
 Why?
Cytomegalovirus Infections
29
2026
203
5.930
 Why?
Influenza Vaccines
29
2021
541
5.750
 Why?
Immunity, Cellular
35
2026
277
5.730
 Why?
T-Lymphocytes, Regulatory
16
2026
411
5.260
 Why?
Antibodies, Viral
45
2026
683
5.190
 Why?
Pregnancy Complications, Infectious
27
2026
437
5.050
 Why?
Cytomegalovirus
28
2026
169
4.370
 Why?
Influenza, Human
27
2021
634
3.860
 Why?
Respiratory Syncytial Virus, Human
7
2026
81
3.310
 Why?
Antiretroviral Therapy, Highly Active
22
2017
278
2.760
 Why?
Immunologic Memory
15
2026
369
2.520
 Why?
Influenza A Virus, H1N1 Subtype
13
2021
161
2.480
 Why?
Pneumococcal Infections
4
2022
104
2.460
 Why?
Vaccines, Attenuated
23
2024
129
2.450
 Why?
T-Lymphocyte Subsets
13
2019
415
2.440
 Why?
Anti-HIV Agents
19
2026
914
2.430
 Why?
T-Lymphocytes
22
2020
2007
2.350
 Why?
Leukocytes, Mononuclear
16
2025
585
2.220
 Why?
CD4-Positive T-Lymphocytes
31
2023
1148
2.080
 Why?
Respiratory Tract Infections
7
2025
399
2.010
 Why?
Respiratory Syncytial Virus Infections
3
2026
139
1.950
 Why?
Isoniazid
7
2026
70
1.670
 Why?
Vaccination
24
2024
1444
1.650
 Why?
Humans
243
2026
145625
1.590
 Why?
Chickenpox
8
2024
83
1.580
 Why?
Antiviral Agents
17
2023
774
1.520
 Why?
Latent Tuberculosis
2
2026
70
1.510
 Why?
Interferon-gamma
20
2022
780
1.510
 Why?
Chickenpox Vaccine
11
2024
75
1.510
 Why?
Female
171
2026
79080
1.480
 Why?
Tuberculosis
7
2026
289
1.470
 Why?
Pregnancy
46
2026
7217
1.460
 Why?
Gastrointestinal Microbiome
3
2026
767
1.450
 Why?
Drug Resistance, Viral
14
2017
126
1.400
 Why?
HIV
8
2022
249
1.380
 Why?
Infant
45
2026
10093
1.370
 Why?
CD8-Positive T-Lymphocytes
12
2019
929
1.310
 Why?
Virus Diseases
4
2018
219
1.310
 Why?
Antitubercular Agents
5
2026
211
1.310
 Why?
DNA, Viral
13
2024
352
1.290
 Why?
Immunogenicity, Vaccine
6
2026
40
1.280
 Why?
Tetanus Toxoid
4
2021
34
1.260
 Why?
Mycobacterium tuberculosis
2
2026
325
1.260
 Why?
Tumor Necrosis Factor Receptor Superfamily, Member 7
11
2009
30
1.230
 Why?
Virus Shedding
6
2017
53
1.220
 Why?
Infectious Disease Transmission, Vertical
10
2023
188
1.210
 Why?
Adult
104
2026
40821
1.200
 Why?
Influenza A virus
9
2013
120
1.160
 Why?
Vaccines, Synthetic
8
2026
138
1.150
 Why?
Influenza B virus
9
2017
47
1.140
 Why?
Male
129
2026
73014
1.120
 Why?
Hepatitis A Vaccines
5
2020
19
1.110
 Why?
Antibodies, Bacterial
5
2022
147
1.100
 Why?
Dermatitis, Atopic
5
2020
319
1.080
 Why?
B-Lymphocytes
7
2021
884
1.050
 Why?
Cord Blood Stem Cell Transplantation
3
2023
103
1.050
 Why?
Adjuvants, Immunologic
8
2021
243
1.040
 Why?
Lymphocyte Activation
28
2020
1136
0.990
 Why?
CD4 Lymphocyte Count
17
2019
280
0.980
 Why?
HIV-1
13
2019
911
0.980
 Why?
Antibody Formation
7
2023
290
0.980
 Why?
Hemagglutination Inhibition Tests
14
2021
38
0.960
 Why?
Infant, Newborn
26
2026
6449
0.950
 Why?
Pneumococcal Vaccines
3
2022
130
0.950
 Why?
Transforming Growth Factor beta
4
2025
466
0.940
 Why?
Anti-Retroviral Agents
8
2023
250
0.940
 Why?
Enzyme-Linked Immunospot Assay
7
2026
40
0.910
 Why?
Breast Feeding
4
2023
447
0.910
 Why?
Transforming Growth Factor beta1
2
2025
176
0.900
 Why?
Interleukin-2
13
2022
434
0.890
 Why?
Monocytes
2
2025
538
0.860
 Why?
Vaccines, Inactivated
10
2017
70
0.860
 Why?
Respiratory Syncytial Viruses
1
2025
58
0.860
 Why?
Viremia
9
2021
158
0.840
 Why?
Viral Load
18
2023
525
0.840
 Why?
Hematopoietic Stem Cell Transplantation
3
2023
700
0.840
 Why?
HIV Protease Inhibitors
3
2019
69
0.800
 Why?
Receptors, Tumor Necrosis Factor
10
2001
162
0.780
 Why?
Immune Reconstitution
1
2023
10
0.780
 Why?
Child
54
2025
22638
0.780
 Why?
Child, Preschool
35
2025
11888
0.780
 Why?
Epstein-Barr Virus Infections
5
2013
102
0.780
 Why?
Environmental Exposure
2
2018
578
0.750
 Why?
Papillomavirus Vaccines
3
2018
296
0.750
 Why?
Double-Blind Method
18
2026
2064
0.740
 Why?
Cytokines
13
2026
2079
0.730
 Why?
Herpesvirus 1, Human
3
2016
87
0.700
 Why?
Adolescent
54
2025
22451
0.690
 Why?
Middle Aged
65
2026
36359
0.680
 Why?
Polymerase Chain Reaction
12
2023
1030
0.670
 Why?
Orthomyxoviridae
3
2017
41
0.670
 Why?
Young Adult
30
2026
14240
0.670
 Why?
Aged
43
2026
26251
0.640
 Why?
DNA-Directed DNA Polymerase
4
2008
48
0.630
 Why?
Vitamin D
2
2024
402
0.620
 Why?
Viral Proteins
5
2012
350
0.620
 Why?
Aged, 80 and over
18
2022
8351
0.620
 Why?
Rotavirus Infections
2
2017
34
0.620
 Why?
Rotavirus Vaccines
2
2017
39
0.620
 Why?
Herpesvirus 4, Human
8
2014
172
0.610
 Why?
Postpartum Period
7
2026
377
0.610
 Why?
Immunosuppressive Agents
7
2014
824
0.610
 Why?
Killer Cells, Natural
5
2026
481
0.600
 Why?
Viral Envelope Proteins
2
2021
97
0.580
 Why?
Medroxyprogesterone Acetate
2
2016
33
0.570
 Why?
Respiratory Syncytial Virus Vaccines
1
2019
39
0.560
 Why?
Antibodies, Neutralizing
7
2021
346
0.560
 Why?
Inflammation
5
2026
2915
0.560
 Why?
RNA, Viral
9
2024
691
0.560
 Why?
Flow Cytometry
12
2026
1160
0.550
 Why?
Simplexvirus
9
2016
80
0.550
 Why?
Paramyxoviridae Infections
2
2011
13
0.550
 Why?
Human papillomavirus 18
1
2018
12
0.550
 Why?
Immunocompromised Host
9
2019
201
0.540
 Why?
Human papillomavirus 16
1
2018
27
0.540
 Why?
Hepatitis A Antibodies
2
2009
3
0.540
 Why?
Cryopreservation
2
2010
115
0.530
 Why?
AIDS-Related Opportunistic Infections
3
2019
130
0.530
 Why?
Th1 Cells
1
2018
138
0.520
 Why?
Lymphocyte Subsets
2
2015
79
0.520
 Why?
Immunization, Secondary
7
2017
93
0.510
 Why?
Immunoglobulin G
9
2026
899
0.510
 Why?
Case-Control Studies
15
2026
3633
0.510
 Why?
Antigens, Viral
8
2017
186
0.500
 Why?
Age Factors
9
2019
3321
0.500
 Why?
Immunoconjugates
2
2013
138
0.500
 Why?
Immunity, Innate
3
2026
843
0.500
 Why?
Mutation
7
2009
4082
0.490
 Why?
Hospitalization
6
2021
2468
0.480
 Why?
Acyclovir
6
2012
97
0.480
 Why?
Encephalomyelitis, Autoimmune, Experimental
5
1999
66
0.480
 Why?
Herpesviridae Infections
5
2013
147
0.480
 Why?
Premature Birth
2
2019
389
0.470
 Why?
Host-Pathogen Interactions
1
2019
366
0.460
 Why?
Viral Vaccines
4
2014
107
0.460
 Why?
Herpes Simplex
4
2016
102
0.440
 Why?
T-Lymphocytes, Cytotoxic
3
2011
180
0.440
 Why?
Reagent Kits, Diagnostic
2
2005
33
0.440
 Why?
Contraceptive Agents, Female
1
2016
80
0.430
 Why?
Central Nervous System Viral Diseases
3
2004
78
0.430
 Why?
B-Lymphocyte Subsets
1
2015
78
0.420
 Why?
Immunoassay
5
2017
108
0.420
 Why?
Immunity, Mucosal
2
2012
97
0.410
 Why?
Injections, Intramuscular
4
2017
140
0.410
 Why?
Foscarnet
6
2008
22
0.410
 Why?
Longitudinal Studies
9
2026
3005
0.400
 Why?
Immunophenotyping
6
2019
324
0.400
 Why?
Transplant Recipients
3
2024
168
0.390
 Why?
Gene Expression Profiling
3
2019
1790
0.390
 Why?
Antigen-Presenting Cells
4
2022
161
0.380
 Why?
B-Lymphocytes, Regulatory
1
2013
3
0.380
 Why?
CD4 Antigens
2
2011
135
0.370
 Why?
Abatacept
3
2026
56
0.370
 Why?
Influenza A Virus, H3N2 Subtype
4
2020
50
0.370
 Why?
Reverse Transcriptase Inhibitors
3
2020
88
0.370
 Why?
Staphylococcus aureus
1
2017
458
0.370
 Why?
Immune Tolerance
2
2013
384
0.360
 Why?
Alphapapillomavirus
1
2012
35
0.360
 Why?
RNA, Ribosomal, 16S
2
2026
507
0.360
 Why?
Vaccines, Conjugate
2
2022
60
0.360
 Why?
Dendritic Cells
2
2026
507
0.360
 Why?
Cell Proliferation
6
2020
2497
0.360
 Why?
Hepatitis A
1
2012
25
0.360
 Why?
Candida
3
2010
46
0.360
 Why?
Skin
1
2017
701
0.350
 Why?
Placebos
5
2017
190
0.350
 Why?
Cohort Studies
11
2023
6045
0.350
 Why?
Polysaccharides
2
2022
88
0.350
 Why?
CD28 Antigens
3
2009
57
0.350
 Why?
Contraceptive Agents
1
2012
65
0.340
 Why?
Metapneumovirus
1
2011
16
0.340
 Why?
Transplantation
1
2011
31
0.340
 Why?
Herpesvirus 2, Human
2
2012
27
0.340
 Why?
Lymphocyte Count
4
2019
166
0.330
 Why?
Lymphoproliferative Disorders
1
2011
59
0.330
 Why?
Benzoxazines
4
2026
31
0.330
 Why?
T-Lymphocytes, Helper-Inducer
7
1994
127
0.330
 Why?
Blood
2
2009
107
0.330
 Why?
Nucleosides
1
2010
25
0.320
 Why?
Drug Therapy, Combination
6
2019
1034
0.320
 Why?
Retrospective Studies
21
2024
17291
0.320
 Why?
Pregnancy Outcome
7
2021
502
0.310
 Why?
Immunoglobulin A
4
2017
205
0.310
 Why?
Programmed Cell Death 1 Receptor
3
2020
268
0.310
 Why?
Cytosine
3
2008
49
0.310
 Why?
Glycoproteins
2
2023
355
0.300
 Why?
Adaptive Immunity
2
2017
172
0.300
 Why?
Nucleotides
1
2010
128
0.300
 Why?
Streptococcus pneumoniae
2
2022
187
0.300
 Why?
Antidepressive Agents
3
2021
234
0.300
 Why?
Refrigeration
1
2009
11
0.300
 Why?
Enzyme-Linked Immunosorbent Assay
8
2021
845
0.300
 Why?
Membrane Glycoproteins
4
2001
495
0.300
 Why?
Immunity, Humoral
2
2021
121
0.300
 Why?
Follow-Up Studies
16
2024
5397
0.290
 Why?
Organophosphonates
3
2008
95
0.290
 Why?
Astrocytes
1
2011
229
0.290
 Why?
Prospective Studies
15
2026
8087
0.290
 Why?
Freezing
1
2009
84
0.290
 Why?
Coculture Techniques
2
2025
244
0.290
 Why?
Cytomegalovirus Retinitis
2
2013
22
0.280
 Why?
Tetanus
2
2009
29
0.280
 Why?
Cyclopropanes
4
2026
83
0.280
 Why?
Alkynes
4
2026
67
0.280
 Why?
Fetal Blood
3
2026
325
0.280
 Why?
Lopinavir
3
2023
30
0.270
 Why?
Biomarkers
9
2026
4329
0.270
 Why?
Interleukin-10
3
2022
310
0.270
 Why?
Time Factors
18
2017
7079
0.270
 Why?
Herpesvirus 7, Human
2
2005
6
0.270
 Why?
Receptors, Antigen, T-Cell, gamma-delta
1
2008
102
0.270
 Why?
Herpesvirus 6, Human
2
2005
14
0.260
 Why?
Glioblastoma
1
2011
349
0.260
 Why?
Specimen Handling
1
2009
178
0.260
 Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2017
973
0.260
 Why?
Norgestrel
1
2007
2
0.260
 Why?
Interleukins
2
2008
247
0.260
 Why?
Apoptosis
7
2011
2436
0.260
 Why?
Incidence
9
2023
2910
0.240
 Why?
Nucleic Acid Hybridization
2
2006
175
0.240
 Why?
Antigens, CD
5
2017
559
0.230
 Why?
Receptors, OX40
10
2001
17
0.230
 Why?
Lung Transplantation
4
2002
326
0.230
 Why?
Acetates
2
2023
78
0.230
 Why?
Coinfection
2
2019
143
0.230
 Why?
Bone Marrow Transplantation
3
2005
298
0.230
 Why?
Lymphokines
5
1994
127
0.220
 Why?
Fibroblasts
4
2025
1033
0.220
 Why?
Ritonavir
2
2016
75
0.220
 Why?
A549 Cells
1
2025
76
0.220
 Why?
Dexamethasone
1
2007
368
0.210
 Why?
Cell Survival
5
2010
1102
0.210
 Why?
Roseolovirus Infections
1
2004
8
0.210
 Why?
Paramyxoviridae
1
2004
2
0.210
 Why?
Measles Vaccine
1
2024
19
0.210
 Why?
Virus Replication
5
2017
525
0.210
 Why?
Chemical and Drug Induced Liver Injury
1
2026
138
0.210
 Why?
Quinazolines
2
2023
267
0.210
 Why?
BCG Vaccine
2
2023
26
0.200
 Why?
RNA, Messenger
10
2011
2783
0.200
 Why?
Ganciclovir
4
2008
51
0.200
 Why?
Forkhead Transcription Factors
3
2011
208
0.200
 Why?
Autoimmune Diseases
3
2014
466
0.200
 Why?
Milk, Human
2
2023
176
0.200
 Why?
Immunity
2
2020
140
0.200
 Why?
Brazil
2
2021
178
0.200
 Why?
Receptors, Immunologic
3
2001
210
0.200
 Why?
Cholecalciferol
1
2024
60
0.200
 Why?
Estradiol
1
2007
517
0.200
 Why?
Drug-Related Side Effects and Adverse Reactions
2
2017
266
0.200
 Why?
Myelin Basic Protein
4
1998
44
0.200
 Why?
Orthomyxoviridae Infections
1
2004
72
0.190
 Why?
Down-Regulation
1
2025
612
0.190
 Why?
Maternal-Fetal Exchange
2
2016
171
0.190
 Why?
Acquired Immunodeficiency Syndrome
2
2023
237
0.190
 Why?
Papillomavirus Infections
2
2018
345
0.190
 Why?
Kaposi Varicelliform Eruption
3
2011
21
0.190
 Why?
Abnormalities, Drug-Induced
1
2023
38
0.190
 Why?
Antirheumatic Agents
1
2026
309
0.190
 Why?
Long-Term Care
1
2024
116
0.190
 Why?
Adenoviridae Infections
1
2023
20
0.190
 Why?
Heart Transplantation
10
2001
679
0.190
 Why?
Isoxazoles
2
2013
56
0.180
 Why?
Zidovudine
2
2015
75
0.180
 Why?
Diabetes Mellitus, Type 1
4
2013
3930
0.180
 Why?
Lamivudine
2
2015
63
0.180
 Why?
Herpes Genitalis
2
2012
17
0.180
 Why?
HIV Integrase Inhibitors
1
2023
80
0.180
 Why?
Liver Failure, Acute
1
2023
70
0.180
 Why?
United States
9
2024
16041
0.180
 Why?
Antibodies, Monoclonal, Murine-Derived
2
2013
96
0.180
 Why?
Genes, Immediate-Early
1
2002
25
0.180
 Why?
Risk Factors
18
2024
10840
0.180
 Why?
Lymphocytosis
1
2021
12
0.180
 Why?
Genes, Viral
1
2002
88
0.170
 Why?
Central Nervous System Diseases
1
2002
73
0.170
 Why?
Antigens, Differentiation
1
2001
75
0.170
 Why?
Tuberculin Test
1
2021
36
0.170
 Why?
South Africa
6
2020
262
0.170
 Why?
Interferon-gamma Release Tests
1
2021
32
0.170
 Why?
Cytotoxicity, Immunologic
2
2002
224
0.170
 Why?
Biliary Atresia
1
2023
161
0.170
 Why?
Maternal Exposure
1
2023
189
0.170
 Why?
Cells, Cultured
11
2010
4112
0.170
 Why?
Organ Transplantation
1
2024
235
0.170
 Why?
Prenatal Exposure Delayed Effects
2
2026
662
0.170
 Why?
Phenotype
7
2009
3186
0.170
 Why?
Treatment Outcome
17
2026
11744
0.170
 Why?
Atazanavir Sulfate
2
2023
41
0.160
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2021
76
0.160
 Why?
Medication Therapy Management
1
2021
73
0.160
 Why?
Evolution, Molecular
1
2005
501
0.160
 Why?
Immunoglobulins
2
2017
162
0.160
 Why?
North America
2
2023
299
0.160
 Why?
Sensitivity and Specificity
5
2009
1992
0.160
 Why?
Virus Activation
3
2013
97
0.160
 Why?
HIV Seronegativity
1
2020
28
0.160
 Why?
Cognitive Dysfunction
1
2026
479
0.160
 Why?
Histocompatibility Antigens Class I
1
2002
207
0.150
 Why?
Virus Cultivation
3
2005
31
0.150
 Why?
Dietary Supplements
1
2024
586
0.150
 Why?
Heart-Assist Devices
8
2000
570
0.150
 Why?
T-Cell Antigen Receptor Specificity
1
2019
45
0.150
 Why?
Interleukin-2 Receptor alpha Subunit
1
2019
82
0.150
 Why?
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
2017
13
0.150
 Why?
Eicosanoids
1
2019
58
0.150
 Why?
Survival Analysis
6
2018
1372
0.140
 Why?
Dose-Response Relationship, Immunologic
2
2016
77
0.140
 Why?
Cholera Toxin
1
2018
27
0.140
 Why?
Arthritis, Rheumatoid
2
2026
1184
0.140
 Why?
Hospitals
1
2023
730
0.140
 Why?
Postoperative Complications
14
2001
2962
0.140
 Why?
Saliva
2
2010
256
0.130
 Why?
Genotype
6
2020
1866
0.130
 Why?
Delayed-Action Preparations
2
2016
191
0.130
 Why?
Fatty Acid-Binding Proteins
1
2018
79
0.130
 Why?
Cell Movement
2
2001
950
0.130
 Why?
Latin America
1
2018
96
0.130
 Why?
Neurodevelopmental Disorders
1
2021
234
0.130
 Why?
CD4-CD8 Ratio
2
2008
23
0.130
 Why?
Lysosomal-Associated Membrane Protein 1
1
2017
12
0.130
 Why?
Cell Line
5
2009
2809
0.130
 Why?
Vaccination Coverage
1
2018
106
0.130
 Why?
Injections, Intradermal
1
2017
13
0.130
 Why?
Coronary Artery Bypass
4
2001
268
0.130
 Why?
Injections, Subcutaneous
2
2016
170
0.130
 Why?
Paralysis
1
2017
69
0.120
 Why?
Arm
1
2017
110
0.120
 Why?
Nervous System Diseases
1
2020
286
0.120
 Why?
Kinetics
3
2010
1553
0.120
 Why?
Seroconversion
1
2017
48
0.120
 Why?
Placenta
2
2021
794
0.120
 Why?
Animals
26
2011
38030
0.120
 Why?
Africa
1
2017
119
0.120
 Why?
Nelfinavir
1
2016
7
0.120
 Why?
Adoptive Transfer
3
2002
197
0.120
 Why?
Liver Transplantation
1
2023
699
0.120
 Why?
Clinical Trials as Topic
2
2019
1062
0.120
 Why?
Base Sequence
6
2017
2119
0.120
 Why?
Cross Reactions
2
2014
129
0.120
 Why?
Demography
2
2018
274
0.110
 Why?
Colorado
2
2023
4588
0.110
 Why?
Comorbidity
2
2019
1652
0.110
 Why?
Seizures
1
2020
489
0.110
 Why?
Aging
3
2017
1983
0.110
 Why?
RNA
1
2022
925
0.110
 Why?
Nevirapine
1
2015
17
0.110
 Why?
Contraceptives, Oral, Synthetic
1
2015
1
0.110
 Why?
Nasopharynx
1
2015
72
0.110
 Why?
Nasal Lavage Fluid
2
2005
14
0.110
 Why?
Transcription, Genetic
1
2021
1429
0.100
 Why?
Infant, Newborn, Diseases
1
2016
113
0.100
 Why?
Immunoenzyme Techniques
2
2006
196
0.100
 Why?
Skin Diseases
1
2016
144
0.100
 Why?
Virus Latency
2
2013
93
0.100
 Why?
Neutropenia
1
2015
153
0.100
 Why?
Multivariate Analysis
5
2017
1531
0.100
 Why?
Seroepidemiologic Studies
2
2024
169
0.100
 Why?
Computational Biology
1
2019
675
0.100
 Why?
Pandemics
2
2021
1700
0.100
 Why?
Graft Rejection
5
2001
504
0.100
 Why?
Antigens, Differentiation, T-Lymphocyte
1
1994
106
0.100
 Why?
Physical Fitness
1
2015
207
0.100
 Why?
Herpesvirus 8, Human
2
2005
66
0.100
 Why?
Progesterone
2
2015
214
0.100
 Why?
Drug Resistance, Multiple, Viral
1
2013
10
0.100
 Why?
Anemia
1
2015
189
0.100
 Why?
Feces
1
2017
494
0.100
 Why?
Rats, Inbred Lew
5
1998
105
0.100
 Why?
Thrombocytopenia
1
2015
205
0.100
 Why?
Leukocyte Common Antigens
2
2009
86
0.090
 Why?
Anesthesiology
1
2016
178
0.090
 Why?
Polyomavirus Infections
1
2013
29
0.090
 Why?
Epitopes, T-Lymphocyte
1
2014
175
0.090
 Why?
Tumor Virus Infections
1
2013
51
0.090
 Why?
Epitopes
2
2009
479
0.090
 Why?
OX40 Ligand
4
2001
10
0.090
 Why?
Mothers
1
2019
771
0.090
 Why?
Proctitis
1
2012
6
0.090
 Why?
Transcriptome
1
2019
1066
0.090
 Why?
Oxadiazoles
1
2012
33
0.090
 Why?
HIV Seropositivity
1
2013
117
0.090
 Why?
Oxidative Stress
1
2019
1367
0.090
 Why?
Aprotinin
3
1997
9
0.090
 Why?
Interferon Regulatory Factor-2
1
2011
3
0.090
 Why?
DNA Primase
1
2012
47
0.090
 Why?
Mycophenolic Acid
1
2012
117
0.090
 Why?
Communicable Diseases
1
2014
165
0.090
 Why?
Depression
1
2021
1566
0.090
 Why?
Fluorescent Antibody Technique, Direct
1
2011
9
0.090
 Why?
Viral Plaque Assay
3
2006
29
0.090
 Why?
L-Selectin
2
2009
27
0.090
 Why?
Receptors, Interleukin-2
2
1990
64
0.080
 Why?
Histocompatibility Testing
3
2001
122
0.080
 Why?
CD8 Antigens
1
2011
70
0.080
 Why?
Guanine
3
2006
85
0.080
 Why?
Encephalitis, Viral
2
2020
45
0.080
 Why?
Ribavirin
1
2011
81
0.080
 Why?
Immunization Schedule
3
2020
186
0.080
 Why?
DNA Helicases
1
2012
138
0.080
 Why?
Fluorescent Antibody Technique
2
2016
345
0.080
 Why?
Motor Activity
1
2015
701
0.080
 Why?
Parturition
1
2011
72
0.080
 Why?
Logistic Models
5
2010
2112
0.080
 Why?
Predictive Value of Tests
3
2005
2097
0.080
 Why?
Herpesvirus Vaccines
1
2010
4
0.080
 Why?
Length of Stay
3
2014
1342
0.080
 Why?
Menstrual Cycle
1
2011
145
0.080
 Why?
Algorithms
3
2021
1843
0.080
 Why?
Immune System
2
2008
181
0.070
 Why?
Herpes Simplex Virus Vaccines
1
2009
4
0.070
 Why?
Pokeweed Mitogens
1
2009
6
0.070
 Why?
Granzymes
1
2009
51
0.070
 Why?
Human Experimentation
1
2009
12
0.070
 Why?
Neuralgia, Postherpetic
1
2009
40
0.070
 Why?
Mice
14
2011
18266
0.070
 Why?
Pilot Projects
2
2026
1878
0.070
 Why?
Immunologic Factors
1
2011
244
0.070
 Why?
Drug Stability
1
2009
168
0.070
 Why?
Plasma
2
2018
222
0.070
 Why?
Apoptosis Regulatory Proteins
1
2009
186
0.070
 Why?
Tumor Necrosis Factor-alpha
1
2014
1223
0.070
 Why?
Gene Rearrangement, T-Lymphocyte
1
2008
15
0.070
 Why?
Cost of Illness
1
2011
322
0.070
 Why?
Nasal Mucosa
1
2009
112
0.070
 Why?
Rats
6
1998
5574
0.070
 Why?
Inflammation Mediators
1
2011
507
0.070
 Why?
Enzyme Inhibitors
1
2012
820
0.070
 Why?
Botswana
2
2019
11
0.070
 Why?
Betaherpesvirinae
1
2008
1
0.070
 Why?
Genetic Variation
2
2011
992
0.070
 Why?
Infant Mortality
2
2019
127
0.070
 Why?
Exodeoxyribonucleases
1
2008
23
0.070
 Why?
Administration, Intranasal
1
2008
94
0.070
 Why?
Interleukin-15
1
2008
96
0.070
 Why?
Cyclosporine
2
2001
256
0.070
 Why?
Interleukin-12
1
2008
115
0.070
 Why?
Trypan Blue
1
2007
5
0.070
 Why?
Didanosine
1
2007
13
0.070
 Why?
Sarcoma
1
2010
209
0.070
 Why?
Thymus Gland
1
2008
310
0.060
 Why?
Gene Expression
3
2006
1461
0.060
 Why?
In Vitro Techniques
3
2006
1041
0.060
 Why?
Data Interpretation, Statistical
1
2009
365
0.060
 Why?
Quality Control
1
2007
162
0.060
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2010
299
0.060
 Why?
Pneumonia
1
2013
633
0.060
 Why?
Cerebrospinal Fluid
2
2004
88
0.060
 Why?
Inhibitory Concentration 50
1
2006
90
0.060
 Why?
Vero Cells
1
2006
84
0.060
 Why?
Transfection
3
2002
914
0.060
 Why?
Drug Interactions
2
2020
403
0.060
 Why?
Multicenter Studies as Topic
2
2006
413
0.060
 Why?
Randomized Controlled Trials as Topic
2
2011
1754
0.060
 Why?
Veterans
1
2018
1647
0.060
 Why?
Antibodies, Monoclonal, Humanized
1
2012
992
0.060
 Why?
Transplantation, Homologous
3
2002
415
0.060
 Why?
Deoxycytidine
1
2007
219
0.060
 Why?
Protein Structure, Tertiary
1
2008
834
0.060
 Why?
Opportunistic Infections
2
2014
47
0.060
 Why?
Hemadsorption
1
2005
1
0.060
 Why?
Cytopathogenic Effect, Viral
1
2005
17
0.060
 Why?
Tumor Necrosis Factors
3
2001
10
0.060
 Why?
Risk Assessment
2
2014
3678
0.060
 Why?
Hemostatics
2
1997
65
0.060
 Why?
Disease Models, Animal
2
2011
4565
0.060
 Why?
Evaluation Studies as Topic
1
2005
160
0.060
 Why?
Signal Transduction
2
2000
5234
0.060
 Why?
Up-Regulation
3
2001
840
0.060
 Why?
Gene Products, pol
1
2005
6
0.050
 Why?
Annexin A5
1
2004
23
0.050
 Why?
Clinical Trials, Phase II as Topic
2
2017
74
0.050
 Why?
Graft vs Host Disease
2
1998
280
0.050
 Why?
Cysteine Proteinase Inhibitors
1
2004
48
0.050
 Why?
Antigens
2
2008
350
0.050
 Why?
Meningitis, Viral
1
2004
19
0.050
 Why?
Parainfluenza Virus 2, Human
1
2004
3
0.050
 Why?
Parainfluenza Virus 1, Human
1
2004
3
0.050
 Why?
Parainfluenza Virus 3, Human
1
2004
5
0.050
 Why?
Pharmacogenetics
1
2026
176
0.050
 Why?
Sarcoma, Kaposi
2
2003
82
0.050
 Why?
Measles virus
1
2024
20
0.050
 Why?
Disease Transmission, Infectious
1
2005
69
0.050
 Why?
Adenoviruses, Human
1
2004
26
0.050
 Why?
Emtricitabine
2
2021
209
0.050
 Why?
Cell Culture Techniques
1
2006
371
0.050
 Why?
Fatal Outcome
1
2005
302
0.050
 Why?
Chlamydophila Infections
1
2003
5
0.050
 Why?
Chlamydophila pneumoniae
1
2003
12
0.050
 Why?
Measles
1
2024
46
0.050
 Why?
HLA-DR Antigens
3
2001
211
0.050
 Why?
Immunotherapy, Adoptive
2
2001
356
0.050
 Why?
Rilpivirine
1
2023
10
0.050
 Why?
Survival Rate
8
2001
2078
0.050
 Why?
Bronchiolitis Obliterans
2
2001
59
0.050
 Why?
Arteriosclerosis
1
2003
82
0.050
 Why?
Portoenterostomy, Hepatic
1
2023
42
0.050
 Why?
Darunavir
1
2023
20
0.050
 Why?
Herpes Labialis
1
2003
9
0.050
 Why?
Cell Line, Tumor
1
2011
3538
0.050
 Why?
Hospital Mortality
4
2001
1037
0.050
 Why?
Leukemia, Myeloid, Acute
1
2010
700
0.050
 Why?
DNA Primers
3
2009
487
0.050
 Why?
Respirovirus
1
2002
6
0.050
 Why?
Pregnancy Trimester, First
1
2023
139
0.050
 Why?
Receptors, Antigen, T-Cell, alpha-beta
2
1994
330
0.050
 Why?
Bronchoalveolar Lavage Fluid
1
2005
641
0.040
 Why?
Risk
1
2005
917
0.040
 Why?
Parapsychology
1
2001
1
0.040
 Why?
Adenoviridae
1
2023
196
0.040
 Why?
Mice, Inbred BALB C
2
2001
1244
0.040
 Why?
Electromagnetic Fields
1
2001
37
0.040
 Why?
Zimbabwe
2
2017
76
0.040
 Why?
Molecular Sequence Data
4
1994
2835
0.040
 Why?
B7-1 Antigen
2
1998
55
0.040
 Why?
Microbial Sensitivity Tests
1
2003
367
0.040
 Why?
Ovalbumin
1
2001
187
0.040
 Why?
Cobicistat
1
2021
5
0.040
 Why?
Living Donors
1
2023
205
0.040
 Why?
Receptors, CXCR5
1
2021
29
0.040
 Why?
Rituximab
2
2013
208
0.040
 Why?
Antibody Affinity
1
2021
60
0.040
 Why?
CTLA-4 Antigen
1
2001
105
0.040
 Why?
Liver Diseases
1
2024
298
0.040
 Why?
Photography
1
2001
120
0.040
 Why?
Prostheses and Implants
3
1996
137
0.040
 Why?
Vaccines, Subunit
1
2021
53
0.040
 Why?
Immunoglobulins, Intravenous
1
2002
134
0.040
 Why?
Gene Expression Regulation
1
1990
2591
0.040
 Why?
Arylamine N-Acetyltransferase
1
2020
8
0.040
 Why?
Cytochrome P-450 CYP2B6
1
2020
9
0.040
 Why?
Models, Statistical
1
2005
667
0.040
 Why?
Analysis of Variance
2
2016
1293
0.040
 Why?
Equivalence Trials as Topic
1
2020
34
0.040
 Why?
Pre-Eclampsia
1
2023
206
0.040
 Why?
Sentinel Lymph Node Biopsy
1
2001
117
0.040
 Why?
Lymphoma
1
2002
251
0.040
 Why?
Metabolic Clearance Rate
1
2020
115
0.040
 Why?
Surface Properties
1
2001
383
0.040
 Why?
DNA
2
2006
1418
0.040
 Why?
Glioma
1
2005
425
0.040
 Why?
Spinal Cord
2
1994
378
0.040
 Why?
Trans-Activators
1
2002
371
0.040
 Why?
Central Nervous System Neoplasms
1
2002
177
0.040
 Why?
Heart Failure
3
1999
2323
0.040
 Why?
Lymphatic Metastasis
1
2001
335
0.040
 Why?
Confusion
1
2020
30
0.040
 Why?
Alanine
1
2021
171
0.040
 Why?
Cancer Vaccines
1
2001
161
0.040
 Why?
Hemodynamics
3
2001
1114
0.040
 Why?
Coronary Disease
2
2001
380
0.040
 Why?
Interleukin-3
3
1994
23
0.040
 Why?
Antibodies
1
2001
395
0.040
 Why?
Liver Function Tests
1
2019
103
0.040
 Why?
Candidiasis
1
1999
64
0.040
 Why?
Triiodothyronine
1
1999
55
0.040
 Why?
California
2
2015
473
0.040
 Why?
Recombinant Fusion Proteins
2
1999
662
0.040
 Why?
Infant, Very Low Birth Weight
1
2019
74
0.040
 Why?
Prognosis
3
2024
4331
0.040
 Why?
Hemagglutination
1
2018
7
0.040
 Why?
Macrophage-1 Antigen
1
1999
26
0.040
 Why?
Hypoplastic Left Heart Syndrome
1
2000
119
0.040
 Why?
Arginine Vasopressin
1
1998
44
0.040
 Why?
Tenofovir
1
2021
300
0.040
 Why?
Polymorphism, Single Nucleotide
3
2011
2228
0.040
 Why?
Cross-Sectional Studies
3
2024
5875
0.040
 Why?
Brain Diseases
1
2020
157
0.030
 Why?
Rats, Inbred BUF
2
1997
2
0.030
 Why?
Adenine
1
2021
338
0.030
 Why?
Neoplasms
3
2001
2944
0.030
 Why?
HLA-B Antigens
1
1998
58
0.030
 Why?
Haptoglobins
1
2018
71
0.030
 Why?
Chronic Disease
1
2024
1824
0.030
 Why?
Vasoconstrictor Agents
1
1998
148
0.030
 Why?
Antibody Specificity
1
1998
181
0.030
 Why?
Immunization
1
2020
375
0.030
 Why?
Delivery, Obstetric
1
2019
164
0.030
 Why?
Protein Precursors
1
2018
127
0.030
 Why?
Clinical Trials, Phase I as Topic
1
2017
49
0.030
 Why?
Shock
1
1998
99
0.030
 Why?
Inositol Phosphates
1
2017
21
0.030
 Why?
Sterols
1
2017
20
0.030
 Why?
Autogenic Training
1
1997
1
0.030
 Why?
Proviruses
1
2017
16
0.030
 Why?
Radioactive Fallout
1
1997
1
0.030
 Why?
Leukemia, Radiation-Induced
1
1997
3
0.030
 Why?
Product Surveillance, Postmarketing
1
2017
74
0.030
 Why?
Sequence Analysis
1
2017
32
0.030
 Why?
Radioactive Hazard Release
1
1997
5
0.030
 Why?
Observational Studies as Topic
1
2017
133
0.030
 Why?
Power Plants
1
1997
8
0.030
 Why?
Relaxation Therapy
1
1997
19
0.030
 Why?
Zambia
1
2017
61
0.030
 Why?
Reproducibility of Results
1
2005
3396
0.030
 Why?
Tanzania
1
2017
74
0.030
 Why?
Encephalitis
1
1998
142
0.030
 Why?
Ligands
1
1999
676
0.030
 Why?
Heart Valves
1
1997
44
0.030
 Why?
Aortic Valve Insufficiency
1
1996
43
0.030
 Why?
Body Weight
1
2020
964
0.030
 Why?
Erythema
1
2016
28
0.030
 Why?
Prevalence
2
2018
2852
0.030
 Why?
Lung Injury
1
2000
262
0.030
 Why?
Neoplasms, Radiation-Induced
1
1997
100
0.030
 Why?
Hemagglutinin Glycoproteins, Influenza Virus
1
2016
33
0.030
 Why?
Fiber Optic Technology
1
2016
23
0.030
 Why?
Heart Arrest, Induced
1
1995
26
0.030
 Why?
Chi-Square Distribution
2
2013
511
0.030
 Why?
Thromboembolism
1
1996
129
0.030
 Why?
Vasodilation
1
1998
519
0.030
 Why?
Intestines
1
2018
351
0.030
 Why?
Reference Values
2
2011
787
0.030
 Why?
DNA-Binding Proteins
1
2002
1467
0.030
 Why?
Interleukin-4
2
1998
207
0.030
 Why?
Blood Transfusion
2
1995
393
0.030
 Why?
Cell Separation
2
2011
300
0.030
 Why?
Single-Blind Method
1
2016
312
0.030
 Why?
Ovulation
1
2015
46
0.030
 Why?
Registries
1
2024
2382
0.030
 Why?
Antibodies, Monoclonal
2
2001
1511
0.030
 Why?
Cross Infection
1
1997
258
0.030
 Why?
Liver
1
2023
1859
0.030
 Why?
Hematologic Neoplasms
1
1997
169
0.030
 Why?
Gene Regulatory Networks
1
2017
319
0.030
 Why?
Hypothermia, Induced
1
1995
96
0.030
 Why?
Blood Loss, Surgical
1
1995
116
0.030
 Why?
HLA-A2 Antigen
1
2014
36
0.030
 Why?
Pulmonary Emphysema
1
1996
276
0.030
 Why?
Surgical Wound Infection
1
1997
331
0.030
 Why?
Aortic Coarctation
1
1994
76
0.030
 Why?
Polymorphism, Restriction Fragment Length
2
2003
57
0.020
 Why?
Colony-Stimulating Factors
2
1990
37
0.020
 Why?
Cross-Over Studies
1
2016
612
0.020
 Why?
Aortic Valve
1
1996
360
0.020
 Why?
Quality of Life
4
2000
3187
0.020
 Why?
Myocardial Infarction
1
2001
1212
0.020
 Why?
Cause of Death
3
2001
455
0.020
 Why?
Growth Substances
2
1990
136
0.020
 Why?
BK Virus
1
2013
18
0.020
 Why?
JC Virus
1
2013
22
0.020
 Why?
Intubation, Intratracheal
1
2016
328
0.020
 Why?
Mice, Inbred Strains
2
1990
384
0.020
 Why?
Herpesviridae
1
2012
21
0.020
 Why?
Drug Administration Schedule
2
2007
782
0.020
 Why?
Genetic Predisposition to Disease
2
2011
2455
0.020
 Why?
Cardiac Surgical Procedures
1
1998
608
0.020
 Why?
Hypersensitivity, Delayed
1
1992
30
0.020
 Why?
Heart Diseases
1
1995
341
0.020
 Why?
Brain Neoplasms
1
2001
1324
0.020
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
2
1990
158
0.020
 Why?
Ventricular Function, Left
1
1995
541
0.020
 Why?
Spleen
1
1994
503
0.020
 Why?
Kaplan-Meier Estimate
1
2014
959
0.020
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2001
1996
0.020
 Why?
Histocompatibility Antigens
1
1992
102
0.020
 Why?
Sex Characteristics
1
2017
798
0.020
 Why?
Patient Selection
1
1995
720
0.020
 Why?
Ambulatory Care
1
1996
627
0.020
 Why?
Metabolomics
1
2017
737
0.020
 Why?
Computer Simulation
1
2016
1014
0.020
 Why?
Matched-Pair Analysis
1
2011
37
0.020
 Why?
Kidney Failure, Chronic
1
1997
582
0.020
 Why?
Receptors, Interferon
1
2011
60
0.020
 Why?
Cattle
2
1990
938
0.020
 Why?
Age of Onset
1
2012
557
0.020
 Why?
Administration, Oral
1
2013
867
0.020
 Why?
Stroke
1
2000
1283
0.020
 Why?
Radiotherapy
2
2005
209
0.020
 Why?
Polyribosomes
1
1990
21
0.020
 Why?
Lung Neoplasms
2
2001
2674
0.020
 Why?
Sequence Homology, Nucleic Acid
1
1990
157
0.020
 Why?
Concanavalin A
1
1990
72
0.020
 Why?
Tetradecanoylphorbol Acetate
1
1990
128
0.020
 Why?
Regulatory Sequences, Nucleic Acid
1
1990
90
0.020
 Why?
Blotting, Northern
1
1990
197
0.020
 Why?
Papillomaviridae
1
2010
113
0.020
 Why?
Genetic Association Studies
1
2011
376
0.020
 Why?
Haplotypes
1
2011
505
0.020
 Why?
Infant, Premature
1
2014
622
0.020
 Why?
Cell Division
2
2002
735
0.020
 Why?
beta-Globins
1
2009
8
0.020
 Why?
Practice Guidelines as Topic
1
2017
1581
0.020
 Why?
Herpesvirus 1, Bovine
1
1989
3
0.020
 Why?
Mice, Knockout
2
2011
3121
0.020
 Why?
Anxiety
1
1997
1118
0.020
 Why?
Immunoglobulin E
1
2010
315
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2011
751
0.020
 Why?
Reference Standards
1
2009
176
0.020
 Why?
Phylogeny
1
2013
921
0.020
 Why?
Multiple Sclerosis
1
1994
434
0.020
 Why?
Ribosomes
1
1990
195
0.020
 Why?
Hematopoietic Stem Cells
2
1990
432
0.020
 Why?
Linear Models
1
2010
847
0.020
 Why?
Infusions, Intravenous
2
1999
429
0.020
 Why?
Membrane Proteins
1
1994
1130
0.020
 Why?
Clinical Competence
1
2016
1261
0.020
 Why?
Time
1
2007
85
0.020
 Why?
Protein Biosynthesis
1
1990
447
0.020
 Why?
Drug Resistance, Multiple
1
2006
25
0.020
 Why?
Kidney Transplantation
1
2013
702
0.020
 Why?
Antineoplastic Agents
2
2010
2218
0.010
 Why?
Clinical Protocols
1
2007
279
0.010
 Why?
Templates, Genetic
1
2005
63
0.010
 Why?
Cell Differentiation
4
2000
1979
0.010
 Why?
Postoperative Care
2
1999
292
0.010
 Why?
Codon
1
2005
92
0.010
 Why?
Internship and Residency
1
2016
1269
0.010
 Why?
Interleukin-5
2
1998
39
0.010
 Why?
Diagnosis, Differential
1
2009
1500
0.010
 Why?
DNA Replication
1
2006
248
0.010
 Why?
Mice, Transgenic
2
2000
2131
0.010
 Why?
Age Distribution
1
2005
395
0.010
 Why?
Sex Distribution
1
2005
379
0.010
 Why?
Vaccines
1
2009
389
0.010
 Why?
Creatinine
2
1997
511
0.010
 Why?
Abdominal Neoplasms
1
2003
48
0.010
 Why?
Lung
1
1996
4119
0.010
 Why?
Endemic Diseases
1
2003
33
0.010
 Why?
Disease Progression
1
2010
2857
0.010
 Why?
Peptide Fragments
2
1998
693
0.010
 Why?
Sequence Analysis, DNA
1
2005
771
0.010
 Why?
Bioelectric Energy Sources
1
2001
4
0.010
 Why?
Fibrosarcoma
1
2001
22
0.010
 Why?
Neuroblastoma
1
2003
177
0.010
 Why?
Galvanic Skin Response
1
2001
26
0.010
 Why?
Electricity
1
2001
26
0.010
 Why?
Electric Conductivity
1
2001
85
0.010
 Why?
Actuarial Analysis
1
2001
15
0.010
 Why?
Injections, Intravenous
1
2001
197
0.010
 Why?
Melanoma, Experimental
1
2001
106
0.010
 Why?
Fingers
1
2001
106
0.010
 Why?
HLA-A Antigens
1
2001
52
0.010
 Why?
Clonal Anergy
1
2001
55
0.010
 Why?
Myocardial Revascularization
1
2001
85
0.010
 Why?
Statistics, Nonparametric
1
2001
423
0.010
 Why?
Immune Sera
1
2000
77
0.010
 Why?
Muscle, Smooth, Vascular
1
2003
449
0.010
 Why?
Anticoagulants
2
1996
743
0.010
 Why?
Lymphocytes, Tumor-Infiltrating
1
2001
155
0.010
 Why?
Amino Acid Sequence
2
1994
2088
0.010
 Why?
Probability
1
2001
308
0.010
 Why?
Clone Cells
1
2000
259
0.010
 Why?
Emergency Treatment
1
2001
122
0.010
 Why?
Mice, Inbred C57BL
2
2001
6021
0.010
 Why?
Databases as Topic
1
2000
70
0.010
 Why?
New York
1
2000
127
0.010
 Why?
Carotid Artery Diseases
1
2000
70
0.010
 Why?
Students
1
2005
647
0.010
 Why?
Peripheral Vascular Diseases
1
2000
102
0.010
 Why?
Columbidae
1
1998
31
0.010
 Why?
Cytochrome c Group
1
1998
43
0.010
 Why?
Cardiotonic Agents
1
1999
94
0.010
 Why?
Lymph Nodes
1
2001
511
0.010
 Why?
Cardiac Output
1
1999
176
0.010
 Why?
Life Tables
1
1998
21
0.010
 Why?
Temperature
1
2001
633
0.010
 Why?
Endocardium
1
1998
31
0.010
 Why?
Aortic Diseases
1
2000
124
0.010
 Why?
Cell Cycle
1
2001
595
0.010
 Why?
Vascular Resistance
1
1999
365
0.010
 Why?
Calcinosis
1
2000
231
0.010
 Why?
Cell Death
1
1999
379
0.010
 Why?
Renal Insufficiency
1
2000
172
0.010
 Why?
Cardiopulmonary Bypass
1
2000
217
0.010
 Why?
Hypotension
1
1998
125
0.010
 Why?
Radiation Chimera
1
1997
28
0.010
 Why?
Phosphorylation
1
2002
1717
0.010
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
1998
228
0.010
 Why?
Endocarditis, Bacterial
1
1997
46
0.010
 Why?
Odds Ratio
1
2000
1070
0.010
 Why?
Ukraine
1
1997
37
0.010
 Why?
Dose-Response Relationship, Drug
1
2001
2018
0.010
 Why?
Lymphocyte Depletion
1
1997
135
0.010
 Why?
Models, Structural
1
1996
40
0.010
 Why?
Lung Volume Measurements
1
1996
44
0.010
 Why?
Radiometry
1
1997
56
0.010
 Why?
Histocompatibility Antigens Class II
1
1998
365
0.010
 Why?
Epidemiologic Methods
1
1997
91
0.010
 Why?
Health Care Costs
1
2000
418
0.010
 Why?
Ultrasonography, Doppler, Transcranial
1
1996
48
0.010
 Why?
Cardiac Output, Low
1
1996
53
0.010
 Why?
Equipment Failure
1
1996
111
0.010
 Why?
Urogenital Neoplasms
1
1995
5
0.010
 Why?
Vital Capacity
1
1996
293
0.010
 Why?
Europe
1
1997
420
0.010
 Why?
Neoplasms, Second Primary
1
1997
103
0.010
 Why?
Pneumonia, Viral
1
2001
387
0.010
 Why?
Forced Expiratory Volume
1
1996
451
0.010
 Why?
Models, Cardiovascular
1
1996
194
0.010
 Why?
Blood Urea Nitrogen
1
1995
53
0.010
 Why?
Heart Valve Prosthesis
1
1997
127
0.010
 Why?
Heart Rate
1
1999
844
0.010
 Why?
Aortic Aneurysm
1
1995
68
0.010
 Why?
Acute Disease
1
1998
1033
0.010
 Why?
Child Development
1
2000
481
0.010
 Why?
Receptors, Antigen, T-Cell
1
1998
676
0.010
 Why?
Equipment Design
1
1996
519
0.010
 Why?
Biopsy
1
1998
1073
0.010
 Why?
Hodgkin Disease
1
1997
173
0.010
 Why?
Waiting Lists
1
1996
242
0.010
 Why?
Proportional Hazards Models
1
1998
1318
0.010
 Why?
Heart Septal Defects, Ventricular
1
1994
44
0.010
 Why?
Reoperation
1
1997
633
0.010
 Why?
Interviews as Topic
1
1997
926
0.010
 Why?
Exercise Test
1
1996
634
0.010
 Why?
Cell Adhesion
1
1994
447
0.010
 Why?
Myocardium
1
1998
948
0.010
 Why?
Smoking
1
2000
1478
0.010
 Why?
Patient Compliance
1
1997
587
0.010
 Why?
Ventricular Function, Right
1
1995
300
0.010
 Why?
Thyroid Neoplasms
1
1997
380
0.010
 Why?
Central Nervous System
1
1994
278
0.010
 Why?
Blood Pressure
1
1998
1761
0.010
 Why?
Feasibility Studies
1
1996
1125
0.010
 Why?
Diabetes Mellitus
1
2000
1101
0.010
 Why?
Head and Neck Neoplasms
1
1995
563
0.000
 Why?
Research Design
1
1997
1139
0.000
 Why?
Lymphocyte Cooperation
1
1990
50
0.000
 Why?
Receptors, Lymphocyte Homing
1
1990
15
0.000
 Why?
Thymectomy
1
1990
15
0.000
 Why?
Antilymphocyte Serum
1
1990
55
0.000
 Why?
Antigens, Surface
1
1990
155
0.000
 Why?
Rabbits
1
1990
647
0.000
 Why?
Infectious Bovine Rhinotracheitis
1
1989
1
0.000
 Why?
Phorbol Esters
1
1989
13
0.000
 Why?
Ionomycin
1
1989
22
0.000
 Why?
Ethers
1
1989
19
0.000
 Why?
Kidney
1
1997
1491
0.000
 Why?
Isoantigens
1
1988
17
0.000
 Why?
Cell-Free System
1
1988
54
0.000
 Why?
Immunotherapy
1
1994
669
0.000
 Why?
Surveys and Questionnaires
1
2000
6050
0.000
 Why?
Breast Neoplasms
1
1997
2411
0.000
 Why?
Models, Biological
1
1988
1758
0.000
 Why?
Weinberg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (839) concept(s)
_
Co-Authors Expand Description
See all (65) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)